The 4th IVC2024 Nucleic Acid Vaccine and Innovative Vaccine Research and Development Technology Forum(hereinafter referred to as "IVC2024") was held in Shanghai Shengnuo on March 1-2emperorThe grand event was held at the Yaguan Holiday Hotel. This grand event is guided by the China Association for the Promotion of Quality and Safety of Food and Drug Enterprises, and jointly organized by the Vaccine and Biological Product Quality Evaluation and Standards Professional Committee of the China Association for the Promotion of Quality and Safety of Food and Drug EnterprisesHosted by Shanghai Baiaotai Pharmaceutical Technology Co., Ltd., with BeiGene, Bowo Biotechnology, CanSino, Minhai Biotechnology, Clover Biotechnology, and Nanotechnology InstrumentsWith strong support, Shanghai Aoshun Business Consulting Co., Ltd. and Pharmaceutical Mastery Bio served as the organizing units, and Hangzhou Yuexin Biotechnology Co., Ltd. served as the co organizers. More than 60 experts, scholars, and 1000 attendees from national review and regulatory agencies, research institutions, and enterprises were invited to gather here. With the support of all parties, the IVC2024 Forum was successfully held and concluded.